Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40004575
Localisation
United Kingdom
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
17/07/2025
Statut
Classification
1.5°C
Année cible
FY2030
Statut
Targets set
Classification
1.5°C
Année cible
FY2050
Overall Net-Zero Target: Dechra TopCo Ltd commits to reach net-zero greenhouse gas emissions across the value chain by FY2050. Near-Term Targets: Dechra TopCo Ltd commits to reduce absolute scope 1 and 2 GHG emissions 42% by FY2030 from a FY2022 base year.* Dechra TopCo Ltd also commits to reduce scope 3 GHG emissions 51.6% per GBP value added within the same timeframe. *The target boundary includes land-related emissions and removals from bioenergy feedstock. Long-Term Targets: Dechra TopCo Ltd commits to reduce absolute scope 1 and 2 GHG emissions 90% by FY2050 from a FY2022 base year.* Dechra TopCo Ltd also commits to reduce scope 3 GHG emissions 97% per GBP value added within the same timeframe. *The target boundary includes land-related emissions and removals from bioenergy feedstock.
Statut
Targets setAnnée cible
FY2050
Statut
BA1.5 memberDate d'engagement
01/06/2021
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
GB0009633180
LEI
213800J4UVB5OWG8VX82
Source : Science Based Targets initiative | Données publiques